Nektar Therapeutics Logo Image

Nektar Therapeutics

Nektar Therapeutics Banner Image

Most Recent Annual Report

2015 Annual Report and Form 10K

Nektar Therapeutics

Nektar Therapeutics does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Nektar Therapeutics

501-1000 Employees
Based in San Francisco, California

Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company’s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology.

Ticker:
NKTR
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Delivery (See More Drug Delivery Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol